European Journal of Heart Failure

NOVEMBER 26, 2024

1.38), a diagnosis of atrial fibrillation (HR 1.24, 95% CI 1.10–1.39), 1.34), ischaemic heart disease (HR 1.20, 95% CI 1.09–1.31), 1.29), diabetes mellitus (HR 1.15, 95% CI 1.04–1.27) m 2 (hazard ratio [HR] 1.75, 95% confidence interval [CI] 1.34–2.27), 2.27), hyperkalaemia (HR 1.73, 95% CI 1.25–2.40),

Heart Failure 71

Heart Failure Kidney Disease Atrial Fibrillation BMI 71

CardiacWire

OCTOBER 27, 2024

It’s well known that heart disease is the U.S.’s s top cause of death, and our rising CVD rates have been widely covered, but a look back on some of the biggest stories of 2024 suggests that cardiovascular disease is about to become a much bigger problem. trillion, representing 4.6% of US GDP.

AFIB 59

AFIB Hypertension Kidney Disease Heart Disease 59

DAIC

SEPTEMBER 11, 2024

million Americans have atrial fibrillation. Atrial fibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought, affecting nearly 5 percent of the population, or 10.5 tim.hodson Wed, 09/11/2024 - 15:40 Sept. million U.S. million U.S.

Atrial Fibrillation 52

Atrial Fibrillation Quality of Life Myocardial Infarction Kidney Disease 52

DAIC

DECEMBER 8, 2023

Getty Images milla1cf Fri, 12/08/2023 - 08:17 December 8, 2023 — The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally managing atrial fibrillation (AFib).

Atrial Fibrillation 52

Atrial Fibrillation AFIB Stroke Strokes 52

DAIC

MARCH 25, 2025

25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies." Additional ACC.25

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Research Academic 52

Stroke Journal

JANUARY 30, 2025

Propensity score-matched analysis (PSM) (1:1) was performed with matching for age, gender, race, BMI, hypertension, diabetes mellitus, chronic kidney disease, hemoglobin level, low-density lipid (LDL) level, left ventricular ejection fraction, and various drugs including ACEi, ARBi, ARNI, beta-blockers, and diuretics.

Outcomes 40

Outcomes Atrial Fibrillation Heart Failure Tachycardia 40

Circulation

NOVEMBER 11, 2024

17.4]) and was also more likely to have diabetes mellitus, hyperlipidemia, chronic lung disease, chronic kidney disease, chronic liver disease, BMI ≥ 25, anemia, metastatic cancer, and atrial fibrillation. The hemophilia cohort was slightly older (63.2[16.8]

Risk Factors 40

Risk Factors Cardiovascular Disease Coronary Artery Bypass Graft Outcomes 40

Circulation: Heart Failure

MARCH 8, 2024

The prevalence of HF risk factors was high: hypertension, 61.9%; former or current smoking, 53.7%; obesity 34.8%; diabetes; 24.7%; and chronic kidney disease; 22%. Overt cardiovascular disease, which ranged from 2.1% (HF) to 13.6% (atrial fibrillation), was less common.

Heart Failure 40

Heart Failure Atherosclerosis Kidney Disease Risk Factors 40

Circulation

NOVEMBER 11, 2024

Logistic regression was used to analyze the relationship between the treatment groups and hospital readmission within 90 days.Results:Only 517 AA met inclusion criteria and did not meet exclusion criteria, which included a history of valvular heart disease, hypertrophic or restrictive cardiomyopathy, active myocarditis, history of cardiac arrest, and (..)

Heart Failure 40

Heart Failure Cardiac Arrest Kidney Disease Atrial Fibrillation 40

European Journal of Heart Failure

JANUARY 20, 2025

Recursive feature elimination was employed to identify the most relevant features in predicting the risk of mortality.

Heart Failure 40

Heart Failure Coronary Artery Disease Myocardial Infarction Kidney Disease 40

Cardiometabolic Health Congress

SEPTEMBER 13, 2024

Measuring eGFR and albuminuria is recommended for assessing kidney disease in all hypertensive patients. Below are some of the most notable highlights: 2024 ESC Updated Clinical Guidelines: Key updates include clopidogrel as a first-line option for long-term use after MI or PCI.

Hypertension 59

Hypertension Cardiovascular Disease Bicuspid/Mitral Arrhythmia 59

Open Heart

JULY 6, 2023

Background Chronic kidney disease (CKD) and atrial fibrillation (AF) are increasing in prevalence globally and share common risk factors. Age, sex, diabetes, hypertension and heart failure were chosen as variables of interest. Methods PubMed, EMBASE and CINAHL were searched from inception to June 2022.

Kidney Disease 52

Kidney Disease Atrial Fibrillation Heart Failure Risk Factors 52

Open Heart

SEPTEMBER 14, 2022

Aims To describe the use of warfarin and direct oral anticoagulants (DOACs) in patients with atrial fibrillation (AF) and chronic kidney disease (CKD), to evaluate changes in renal function over time and predictors of rapid decline, and to describe time in therapeutic range (TTR) and predictors of poor TTR among patients on warfarin.

Kidney Disease 52

Kidney Disease Atrial Fibrillation Heart Failure Diabetes 52

Open Heart

JANUARY 13, 2023

Objectives Accurate prediction of heart failure (HF) patients at high risk of atrial fibrillation (AF) represents a potentially valuable tool to inform shared decision making. No validated prediction model for AF in HF is currently available. The objective was to develop clinical prediction models for 1-year risk of AF.

Atrial Fibrillation 52

Atrial Fibrillation Heart Failure Myocardial Infarction Kidney Disease 52

Circulation

NOVEMBER 11, 2024

It is highly recommended to screen for liver fibrosis in patients with Type 2 diabetes mellitus (T2DM) and elevated liver enzymes using the fibrosis-4 (FIB-4) score.However, this recommendation does not extend to patients with chronic heart failure (CHF) who do not have T2DM. 1.45), cardiovascular mortality (HR: 1.80, 95% CI: 1.49-2.17),

Heart Failure 40

Heart Failure Diabetes Myocardial Infarction Kidney Disease 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

In multivariate regression analysis, the factors independently associated with a greater risk of readmission within 90 days were hypercoagulation (1.359 [95%CI, 1.1274‐1.45]), opiod abuse and dependence (1.353 [95%CI, 1.238‐1.478]), chronic kidney disease (1.347 [95%CI, 1.316‐1.379]), liver disease (1.318 [95% CI, 1.26‐1.378]),

Risk Factors 40

Risk Factors Stroke Strokes Medicare 40

Stroke Journal

FEBRUARY 1, 2024

Characteristics associated with intracranial stent utilization were male sex, history of diabetes, hypertension, or chronic kidney disease, absence of atrial fibrillation or CHF, and southern US region. women; mean age, 69.1 [SD, years; mean NIHSS score of 15.1 [SD, years; mean NIHSS score of 13.8 [SD,

Stents 40

Stents Stent Stroke Strokes 40